BRIO is Bordeaux’s integrated cancer research site (SIRIC). It connects multidisciplinary research teams on the same site, working in synergy to produce new knowledge in oncology and fast-track its transfer for the benefit of patients.
BRIO is one of eight sites accredited by the French National Cancer Institute (INCa) for 2018-2022. This second accreditation was awarded to BRIO, among other things, for its innovative research programme selection process. Twenty-seven international experts were designated by BRIO and submitted with 9 multidisciplinary research programmes (designed by Bordeaux researchers). Following that process, three programmes were selected :
Through those programmes, BRIO calls on the skills of researchers in a wide range of fields involved in the fight against cancer :
biology, epidemiology, clinical medicine, sociology, physical sciences, chemistry, psychology, computer science, philosophy, mathematics, etc.
BRIO also stands out thanks to its strategy for bringing patients closer to and involving them in its research. It has included patients in both its Trustees Committee and its international Scientific Advisory Committee, who accompany BRIO in its management. In 2015, it also set up ASPERON & Co (Associations and Patients Committed to Oncology Research & Professional Community), a collective made up of over 100 patients, ex-patients, caregivers, volunteers from associations and professionals from the health and research community. Together, they imagine and carry out projects to improve collaboration and communication in cancer research. BRIO relies on ideas from ASPERON & Co members for its mission aimed at transferring and disseminating oncology research know-how and findings.
BRIO plays a role in structuring the cancer research community in Bordeaux and Nouvelle Aquitaine, which is currently reflected by the Oncosphere project.